Complex left main coronary artery disease
Conditions
Interventions
Subjects With MACCE and Subjects Without MACCE:NA
Sponsors
Wuhan Asia Heart Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.The patient must be >=18 years of age; 2.The patient has a lesion of >= 50% in the left main coronary artery, along with clear indications for PCI suggested by the treating interventionalist; 3.The patient is willing to undergo percutaneous coronary intervention (PCI) guided by intravascular ultrasound (IVUS). 4.Silent ischemia, stable angina, unstable angina, non-ST-segment elevation MI (NSTEMI), ST-segment elevation MI (STEMI); 5.Able to understand and provide informed consent and comply with all study procedures.
Exclusion criteria
Exclusion criteria: 1.Female patients who are pregnant or nursing; 2.cardiogenic shock; 3.Prior PCI of the LM at any time prior to enrollment; 4.Patients unable to tolerate, obtain or comply with dual antiplatelet therapy for at least 6 months in stable patients and 1 year in ACS patients; 5.Complicated with severe hepatic insufficiency or renal insufficiency. 6.Complicated with severe coagulation abnormalities. 7.Complicated with malignant tumors. 8.Non-cardiac co-morbidities with a life expectancy less than 1 years; 9.Currently participating in another trial that is not yet at its primary outcome; the patient is not allowed to participate in another investigational device or drug study for at least 12 months after enrollment;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Composite endpoint: major adverse cardiac and cerebrovascular event (MACCE) include cardiac death, myocardial infarction, target vessel revascularization, non - fatal stroke; | — |
Countries
China
Contacts
Public ContactHua Yan
Wuhan Asia Heart Hospital
Outcome results
None listed